Stryker Net Profit Margin 2010-2025 | SYK

Current and historical net profit margin for Stryker (SYK) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Stryker net profit margin for the three months ending March 31, 2025 was .
Stryker Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $23.22B $2.86B 12.31%
2024-12-31 $22.60B $2.99B 13.25%
2024-09-30 $21.97B $3.59B 16.34%
2024-06-30 $21.39B $3.45B 16.12%
2024-03-31 $20.96B $3.36B 16.03%
2023-12-31 $20.50B $3.17B 15.44%
2023-09-30 $19.89B $2.59B 13.00%
2023-06-30 $19.46B $2.71B 13.92%
2023-03-31 $18.95B $2.63B 13.86%
2022-12-31 $18.45B $2.36B 12.78%
2022-09-30 $17.95B $2.46B 13.69%
2022-06-30 $17.63B $2.08B 11.79%
2022-03-31 $17.43B $2.02B 11.56%
2021-12-31 $17.11B $1.99B 11.66%
2021-09-30 $16.67B $1.90B 11.40%
2021-06-30 $16.25B $2.08B 12.82%
2021-03-31 $14.72B $1.41B 9.57%
2020-12-31 $14.35B $1.60B 11.14%
2020-09-30 $14.22B $1.76B 12.35%
2020-06-30 $14.07B $1.60B 11.38%
2020-03-31 $14.96B $2.16B 14.47%
2019-12-31 $14.88B $2.08B 13.99%
2019-09-30 $14.55B $3.43B 23.55%
2019-06-30 $14.20B $3.55B 24.99%
2019-03-31 $13.88B $3.52B 25.38%
2018-12-31 $13.60B $3.55B 26.12%
2018-09-30 $13.28B $1.24B 9.31%
2018-06-30 $13.04B $1.08B 8.28%
2018-03-31 $12.73B $1.02B 8.00%
2017-12-31 $12.44B $1.02B 8.20%
2017-09-30 $12.13B $1.78B 14.67%
2017-06-30 $11.96B $1.70B 14.22%
2017-03-31 $11.79B $1.69B 14.33%
2016-12-31 $11.33B $1.65B 14.54%
2016-09-30 $10.88B $1.66B 15.24%
2016-06-30 $10.47B $1.61B 15.33%
2016-03-31 $10.06B $1.62B 16.07%
2015-12-31 $9.95B $1.44B 14.47%
2015-09-30 $9.85B $1.18B 11.95%
2015-06-30 $9.82B $0.93B 9.50%
2015-03-31 $9.75B $0.67B 6.86%
2014-12-31 $9.68B $0.52B 5.32%
2014-09-30 $9.53B $0.64B 6.73%
2014-06-30 $9.29B $0.69B 7.40%
2014-03-31 $9.14B $0.77B 8.45%
2013-12-31 $9.02B $1.01B 11.15%
2013-09-30 $8.89B $0.89B 10.01%
2013-06-30 $8.79B $1.14B 12.97%
2013-03-31 $8.69B $1.25B 14.41%
2012-12-31 $8.66B $1.30B 14.99%
2012-09-30 $8.53B $1.43B 16.74%
2012-06-30 $8.51B $1.40B 16.48%
2012-03-31 $8.45B $1.39B 16.42%
2011-12-31 $8.31B $1.35B 16.19%
2011-09-30 $8.09B $1.24B 15.32%
2011-06-30 $7.82B $1.25B 15.96%
2011-03-31 $7.54B $1.26B 16.69%
2010-12-31 $7.32B $1.27B 17.39%
2010-09-30 $7.16B $1.28B 17.94%
2010-06-30 $7.04B $1.18B 16.70%
2010-03-31 $6.92B $1.15B 16.59%
2009-12-31 $6.72B $1.11B 16.47%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $145.939B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.137B 27.79
Boston Scientific (BSX) United States $154.602B 38.70
EssilorLuxottica (ESLOY) France $128.884B 0.00
Medtronic (MDT) Ireland $105.694B 14.98
Haleon (HLN) United Kingdom $51.038B 29.05
Lonza Group Ag (LZAGY) Switzerland $49.182B 0.00
ResMed (RMD) United States $35.941B 27.00
GE HealthCare Technologies (GEHC) United States $32.753B 15.55
Agilent Technologies (A) United States $32.296B 20.98
Terumo (TRUMY) Japan $27.790B 36.10
Insulet (PODD) United States $22.791B 89.46
Koninklijke Philips (PHG) Netherlands $21.581B 15.51
Zimmer Biomet Holdings (ZBH) United States $18.467B 11.86
Baxter (BAX) United States $15.754B 11.76
Smith & Nephew SNATS (SNN) United Kingdom $12.622B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.194B 21.55
Lantheus Holdings (LNTH) United States $5.225B 13.18
Prestige Consumer Healthcare (PBH) United States $4.175B 18.65
Perrigo (PRGO) Ireland $3.730B 9.45
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.309B 24.40
Haemonetics (HAE) United States $3.259B 14.85
Envista Holdings (NVST) United States $3.129B 26.00
GN Store Nord (GNNDY) Denmark $2.215B 18.35
QuidelOrtho (QDEL) United States $2.080B 14.30
LeMaitre Vascular (LMAT) United States $1.832B 40.94
AtriCure (ATRC) United States $1.687B 0.00
Neogen (NEOG) United States $1.348B 17.25
Acuren (TIC) United States $1.300B 0.00
AdaptHealth (AHCO) United States $1.212B 12.30
Kestra Medical Technologies (KMTS) United States $1.165B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
BioLife Solutions (BLFS) United States $1.060B 0.00
Phibro Animal Health (PAHC) United States $1.000B 12.78
InMode (INMD) Israel $0.922B 9.29
CeriBell (CBLL) United States $0.615B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.604B 0.00
Evolus (EOLS) United States $0.602B 0.00
Curaleaf Holdings (CURLF) Canada $0.582B 0.00
Valneva SE (VALN) France $0.535B 0.00
Owens & Minor (OMI) United States $0.502B 4.17
Tilray Brands (TLRY) Canada $0.468B 0.00
Capricor Therapeutics (CAPR) United States $0.461B 0.00
Surmodics (SRDX) United States $0.422B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.342B 0.00
Cresco Labs (CRLBF) United States $0.333B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.94
Canopy Growth (CGC) Canada $0.314B 0.00
Aurora Cannabis (ACB) Canada $0.310B 55.20
Sanara MedTech (SMTI) United States $0.261B 0.00
Viemed Healthcare (VMD) United States $0.260B 21.90
ZimVie (ZIMV) United States $0.250B 11.35
Sanuwave Health (SNWV) United States $0.241B 0.00
Verano Holdings (VRNOF) United States $0.237B 0.00
Cerus (CERS) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.207B 0.00
Quanterix (QTRX) United States $0.203B 0.00
Brainsway (BWAY) Israel $0.197B 52.15
Biote (BTMD) United States $0.197B 5.53
Omeros (OMER) United States $0.195B 0.00
Organigram Global (OGI) Canada $0.185B 0.00
High Tide (HITI) Canada $0.177B 0.00
Utah Medical Products (UTMD) United States $0.177B 14.44
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.142B 17.46
Jin Medical (ZJYL) China $0.119B 0.00
TerrAscend (TSNDF) Canada $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.089B 11.52
MacroGenics (MGNX) United States $0.088B 0.00
Agape ATP (ATPC) $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.077B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.072B 0.00
Apyx Medical (APYX) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
United Health Products (UEEC) United States $0.054B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Modular Medical (MODD) United States $0.048B 0.00
United-Guardian (UG) United States $0.038B 13.19
Rockwell Medical (RMTI) United States $0.032B 0.00
Nephros (NEPH) United States $0.028B 37.57
Safety Shot (SHOT) United States $0.021B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00